PSTV - Plus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

PSTV is currently covered by 3 analysts with an average price target of $27.67. This is a potential upside of $23.83 (620.57%) from yesterday's end of day stock price of $3.84.

Plus Therapeutics's activity chart (see below) currently has 37 price targets and 55 ratings on display. The stock rating distribution of PSTV is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 49.7% of the time, taking 208.83 days on average.

Highest price target for PSTV is $57, Lowest price target is $1, average price target is $27.67.

Most recent stock forecast was given by from ASCENDIANT on 08-Jun-2026. First documented stock forecast 28-Jun-2016.

Best performing analysts who are covering PSTV - Plus Therapeutics:

Andrew D'silva Jason Kolbert Edward Woo Sean Lee Jason Mccarthy Joseph Pantginis

Currently out of the existing stock ratings of PSTV, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Jan-2020

$57

$52.8 (1257.14%)

$65

5 months 13 days ago
(08-Jun-2026)

1/4 (25%)

$51.47 (930.74%)

831

Buy Since 18-Sep-2025

7 months 21 days ago
(31-Mar-2026)

3/5 (60%)

$4.54 (986.96%)

119

Buy Since 11-Feb-2021

$1

$-3.2 (-76.19%)

$2

9 months 29 days ago
(23-Jan-2026)

5/7 (71.43%)

$0.73 (270.37%)

266

Buy Since 16-Oct-2020

$3

1 years 3 months 3 days ago
(18-Aug-2025)

2/5 (40%)

$2.46 (455.56%)

499

Buy Since 24-Apr-2023

$10

$71

2 years 3 days ago
(18-Nov-2024)

0/3 (0%)

$8.81 (740.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PSTV (Plus Therapeutics) average time for price targets to be met?

On average it took 209 days for the stock forecasts to be reached, with an average price target met ratio of 49.7%.

Which analyst most recently updated their price target on PSTV (Plus Therapeutics)?

Which analyst has the most public recommendations on PSTV (Plus Therapeutics)?

has 0 price targets and 0 ratings on PSTV

Which analyst is the currently most bullish on PSTV (Plus Therapeutics)?

Joseph Pantginis with the highest potential upside of $8248.84

Which analyst is the currently most reserved on PSTV (Plus Therapeutics)?

Sean Lee with the lowest potential downside of -$3.2
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?